# Keros Therapeutics, Inc.: Form SCHEDULE 13D, filed Apr 11, 2025

- Company: [Keros Therapeutics, Inc.](/companies/kros.md) (CIK 1664710)
- Form: SCHEDULE 13D
- Filed: 2025-04-11
- Accepted by EDGAR: Apr 11, 2025, 20:32 ET
- Period: not reported
- Accession: 0001104659-25-034310
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1664710/000110465925034310/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1664710/000110465925034310/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1664710/000110465925034310/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Apr 11, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-034310. Last ingested by Listed: Nov 5, 2026, 17:32 ET. No prices; not investment advice.